Description

Sodium Valproate

Sodium Valproate is a high-purity, pharmaceutical-grade antiepileptic agent used in oral and injectable formulations for the treatment of epilepsy, bipolar disorder, and migraine prophylaxis. As the sodium salt of Valproic acid, it offers enhanced water solubility and rapid systemic absorption, making it suitable for immediate-release, extended-release, and parenteral dosage forms. Sodium Valproate is

• A pharmaceutical-grade anticonvulsant and mood stabilizer
• Sodium salt that provides enhanced solubility and bioavailability
• Indicated for epilepsy, bipolar disorder, and migraine prophylaxis
• Suitable for tablets, capsules, oral solutions, and intravenous formulations

Chemically known as the Sodium salt of 2-Propylpentanoic acid, Sodium Valproate exerts its therapeutic effects by increasing brain concentrations of γ-Aminobutyric acid (GABA), an inhibitory neurotransmitter. It modulates voltage-gated sodium channels and T-type calcium channels, contributing to its broad-spectrum anticonvulsant activity.

In pharmaceutical applications, Sodium Valproate is used in:

• Oral solid dosage forms for monotherapy or adjunctive therapy in epilepsy
• Extended-release tablets and sprinkle capsules for once-daily dosing in seizure or mood control
• Liquid oral suspensions for pediatric and geriatric administration
• Parenteral formulations (IV injection/infusion) for acute seizure control or when oral dosing is not possible

CarboMer supplies Sodium Valproate with rigorous control over purity, particle size, and impurity profile. The material conforms to pharmacopeial standards (e.g., USP, EP) and is suitable for scale-up and global regulatory submission.

Product is packaged in sealed, tamper-evident containers designed for moisture protection and long-term storage stability. Available in standard and custom pack sizes with minimum order quantities (MOQ) and lead time options to support clinical development and commercial production.

Each batch is tested per pharmacopeial requirements for identity, assay, pH, loss on drying, related substances, and microbial limits.

As with all CarboMer APIs, Sodium Valproate is supported by expert formulation consultation, regulatory assistance, and lifecycle documentation services helping pharmaceutical manufacturers bring high-quality CNS therapies to market with confidence.